Wickel D J, Cheadle W G, Mercer-Jones M A, Garrison R N
Department of Surgery, University of Louisville School of Medicine, KY, USA.
Ann Surg. 1997 Jun;225(6):744-53; discussion 753-6. doi: 10.1097/00000658-199706000-00012.
The purpose of the study is to determine whether organ failure develops in patients despite control of peritoneal infection and whether the process is, in part, neutrophil (polymorphonuclear leukocyte [PMN]) mediated.
Peritonitis generally responds to prompt surgical intervention and systemic antibiotics; however, some patients continue a septic course and progress to organ failure and death.
One hundred five consecutive patients with peritonitis between 1988 and 1996 who required operation and a postoperative hospital stay greater than 10 days were studied. Mice were injected with a monoclonal anti-PMN antibody 24 hours before cecal ligation and puncture (CLP) to deplete PMNs.
Thirty-eight patients died, and all but 1 had identified organ failure. Seventy-seven patients had either pulmonary failure alone (25 patients) or as a component of multisystem organ failure (52 patients). All but one of these patients showed resolution of their intraperitoneal infection as evident by clinical course, abdominal computed tomographic scan, second-look laparotomy, or autopsy. Recurrent intra-abdominal infection developed in 15 patients, but only 1 had organ failure, and 2 died. At 18 hours after CLP, lung injury, PMN content, interleukin-1 mRNA expression, and liver injury were significantly reduced by anti-PMN treatment, whereas serum endotoxin levels actually increased.
Disease acuity and organ failure, and not recurrent peritoneal infection, are the major causes of adverse outcome in patients with peritonitis. The authors' experimental data indicate that such organ injury is, in part, PMN mediated but not endotoxin mediated. Attraction of PMNs toward the site of primary infection, and thereby away from remote organs, is a logical future therapeutic approach in such patients who are critically ill with peritonitis.
本研究旨在确定尽管腹膜感染得到控制,患者是否仍会发生器官衰竭,以及该过程是否部分由中性粒细胞(多形核白细胞[PMN])介导。
腹膜炎通常对及时的手术干预和全身抗生素治疗有反应;然而,一些患者仍会继续败血症病程,并进展为器官衰竭和死亡。
对1988年至1996年间连续105例需要手术且术后住院时间超过10天的腹膜炎患者进行研究。在盲肠结扎和穿刺(CLP)前24小时给小鼠注射单克隆抗PMN抗体以消耗PMN。
38例患者死亡,除1例患者外,其余均出现明确的器官衰竭。77例患者单独出现肺衰竭(25例)或作为多系统器官衰竭的一部分(52例)。从临床病程、腹部计算机断层扫描、二次剖腹探查或尸检来看,除1例患者外,所有这些患者的腹腔内感染均得到缓解。15例患者发生复发性腹腔内感染,但只有1例出现器官衰竭,2例死亡。CLP后18小时,抗PMN治疗可显著降低肺损伤、PMN含量、白细胞介素-1 mRNA表达和肝损伤,而血清内毒素水平实际上升高。
疾病的严重程度和器官衰竭而非复发性腹膜感染是腹膜炎患者不良结局的主要原因。作者的实验数据表明,这种器官损伤部分由PMN介导而非内毒素介导。对于患有严重腹膜炎的此类患者,将PMN吸引至原发性感染部位,从而使其远离远处器官,是一种合理的未来治疗方法。